Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 07, 2022
Charles River Laboratories International and Cure AP-4, a non-profit foundation dedicated to raising funds and awareness about Adapter-Protein 4 Hereditary Spastic Paraplegia (AP-4 HSP), have announced a manufacturing collaboration.
read more
Thursday, September 08, 2022
Hovione has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal.
read more
Thursday, September 08, 2022
Cytel expanded its operations into the Asia-Pacific region (APAC). This enables biotech and biopharma companies in APAC to have easier access to Cytel’s established biometrics and advanced statistical solutions.
read more
Thursday, September 08, 2022
Medigen is doubling the amount of space leased at Riverside Technology Park in Frederick, Maryland to 12,000 square feet, which represents the second time the biotech company has expanded its operations at 8420 Gas House Pike within the last 36 ...
read more
Thursday, September 08, 2022
Flagship Biosciences announced the acquisition of Interpace Pharma Solutions ("IPS"), a division of Interpace Biosciences and provider of cytogenetic, molecular pathology, and genomic profiling solutions.
read more
Thursday, September 08, 2022
Aptar Pharma has acquired Metaphase Design Group, a leader in applying the science of human factors engineering and ergonomics to product design.
read more
Thursday, September 08, 2022
Lonza agrees to cooperate with Touchlight to aid in genetic medicine advancement. Through this collaboration, Lonza will have the ability to integrate an additional,
read more
Monday, September 12, 2022
KCAS Bioanalytical and Biomarker Services (KCAS), a bioanalytical contract research organization (CRO), backed by Vitruvian Partners, closed the purchase of Active Biomarkers, located in Lyon, France.
read more
Wednesday, September 14, 2022
Following their recent expansion into formulation, method and lyo development, Berkshire Sterile Manufacturing (BSM) now offers two new services to assist their clients in their R&D efforts as they head towards clinical development and trials.
read more
Thursday, September 15, 2022
The development of new drug products and forms of therapy is progressing rapidly. For contract developers and manufacturers, this means staying on the cutting edge of production technologies and actively supporting customers with innovative ...
read more
Thursday, September 15, 2022
Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of TWi Pharmaceutical Co.Ltd, a technology-based company specializing in development and commercialization of niche generic ...
read more
Monday, September 19, 2022
LSPediA Inc., a cloud solutions provider for the pharmaceutical industry, added Patrick O'Donohue to its Leadership Team as Vice President of Operations.
read more
Wednesday, September 21, 2022
Johnson & Johnson opened its San Francisco Bay Campus, a state-of-the-art Research & Development (R&D) facility in the Bay Area, one of the world’s most established global hubs for innovation and entrepreneurship.
read more
Wednesday, September 21, 2022
Merck will initiate a new Phase 3 clinical program with once-daily islatravir for the treatment of people with HIV-1 infection.
read more
Wednesday, September 21, 2022
WuXi Biologics announced that its two Drug Substance (DS) facilities and a Drug Product (DP) facility located in Wuxi city received regulatory approvals from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA).
read more